公司资料
Akili 股价、新闻与催化剂
- 股票代码:
- AKLI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for AKLI.
公司概览
业务概览
Akili was a digital therapeutics company focused on cognitive treatment and software-based interventions before its public-market decline and restructuring. Its business centered on prescription digital medicine.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Akili sat in digital health.
商业模式特征
The company depended on product adoption, reimbursement, and the commercialization of software-based therapeutics.
生物医药行业定位
Akili belongs to the historical digital-therapeutics category rather than the current live public-company set.
未来催化剂
- Akili’s catalysts are now mostly strategic and closeout-related, with any remaining update focused on how the company’s digital-therapeutics assets are being positioned or monetized. The market will care more about corporate clarity than about a fresh product cycle.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。